Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Endometriosis Drugs
... at a CAGR of 3.0% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Tinea Pedis (Athlete`s Foot) Treatment
... is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Topical Administration, one of the segments analyzed in the report, is expected to record a 3.3% ... Read More
-
Label-Free Detection
... at a CAGR of 7.0% over the analysis period 2023-2030. Label-Free Detection Instruments, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.4 Billion by the end ... Read More
-
Duchenne Muscular Dystrophy Drugs
... reach US$27.4 Billion by 2030, growing at a CAGR of 38.6% over the analysis period 2023-2030. Exon Skipping Drugs, one of the segments analyzed in the report, is expected to record a 43.9% CAGR and ... Read More
-
Colorectal Cancer Therapeutics
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by ... Read More
-
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
... reached US$ 1,445.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,448.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.85% during 2024-2032. The rising healthcare spending, favorable reimbursement ... Read More
-
Cancer/Tumor Profiling Market Report by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In-Situ Hybridization (ISH), Microarray, and Others), Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032
... Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032 The global cancer/tumor profiling market size reached US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the ... Read More
-
Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global nuclear medicine market size is expected to reach USD 34.51 billion by 2030, registering a CAGR of 11.69% from 2024 to 2030, according to a new report by Grand View Research, ... Read More
-
Shingles - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Shingles: Understanding ... Read More
-
Urticaria- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Urticaria: Understanding Urticaria: Overview ... Read More
-
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the escalating incidence of unintended pregnancies, increased awareness and education ... Read More
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Asia Pacific, Middle East & Africa) Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Migraine Drugs
... at a CAGR of 16.1% over the analysis period 2023-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... the year 2023, is expected to reach US$57.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Stimulant Drugs, one of the segments analyzed in the report, is expected to ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Epigenetics
... of 13.3% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Global AI in Drug Discovery Market 2024-2031
... and others), by Application (Drug Optimization and Repurposing, Preclinical Testing and Drug Screening) and by End-Users (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Research Centers and Academic & Government Institutes), Forecast Period (2024-2031) ... Read More
-
Global Narcolepsy Drugs Market Report by Therapeutic Type (Sodium Oxybate, Central Nervous Systems Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, Others) Disease Type (Cataplexia, Daytime Extreme Sleepiness, Other Disease type) End Users (Hospitals, Diagnostics Centers, Others) Countries and Company Analysis, 2024-2032
... Others) Countries and Company Analysis, 2024-2032 Narcolepsy Drugs Market Analysis Narcolepsy drugs market is predicted to be over US$ 6,947 million through 2032 from US$ 3,471. 3 million in 2023. It demonstrates a compound annual ... Read More
-
Severe Asthma - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Sepsis Therapeutics
... at a CAGR of 6.5% over the analysis period 2023-2030. Cephalosporin Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Acute Myeloid Leukemia (AML) Therapeutics
... is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.5% CAGR ... Read More
-
ADME-Toxicology Testing
... at a CAGR of 10.9% over the analysis period 2023-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$9.6 Billion by the end ... Read More
-
Growth Hormone Deficiency Market Size, Share & Segmentation, by Type, by Indication, by Distribution Channel, By Regions | Global Market Forecast 2024-2031
... insights into a specific market, industry, or sector. It involves the systematic collection, analysis, and interpretation of data related to market conditions, consumer behaviors, competitive landscapes, and emerging trends. The primary purpose of a market ... Read More
-
Lung Cancer Therapeutics
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More
Research Assistance
